Gingerols

Pharmacology & Research

Gingerols are the main pungent principles of fresh ginger, and “gingerol” chiefly means ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol, the most abundant homolog (with minor 8- and 10-gingerol). Two facts frame the evidence. First, gingerol is thermally labile — on drying or heating it dehydrates to the sharper shogaols and, with further cooking, to milder zingerone — so fresh and dried rhizome differ in their gingerol:shogaol ratio, and any “ginger” result depends on the preparation. Second, and decisively, almost all human efficacy evidence is for whole or standardised ginger extract, not isolated ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol — the isolate’s role is mechanistic. Those mechanisms are well defined: ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol is a 5-HT3 receptor negative allosteric modulator and NK-1 antagonist (the antiemetic basis) ^{1,2Reference 1Marx W et al. · 2017ReviewGinger — mechanism of action in chemotherapy-induced nausea and vomiting: a reviewView study →Reference 2Al Kury LT et al. · 2018Natural negative allosteric modulators of 5-HT3 receptorsView study →} and a TRPV1 agonist ^{8Reference 8Yin Y et al. · 2019Structural mechanisms underlying activation of TRPV1 channels by pungent compounds in gingersView study →}, and it inhibits COX/LOX and NF-κB inflammatory signalling ^{3,10Reference 3Jalali M et al. · 2020Meta-analysisThe effects of ginger supplementation on markers of inflammatory and oxidative stress: a systematic review and meta-analysisView study →Reference 10Jeong CH et al. · 2009Jeong CH, et al. (2009). [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Research. https://pubmed.ncbi.nlm.nih.gov/19531649/View study →}.

1. Anti-nausea (antiemetic)

Ginger’s best-evidenced use: meta-analyses support it for pregnancy-associated nausea and vomiting ^{13Reference 13Viljoen E et al. · 2014Meta-analysisA systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomitingView study →}, and ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol is a plausible active via 5-HT3 receptor negative allosteric modulation and NK-1 antagonism — the same targets as standard antiemetics ^{1,2Reference 1Marx W et al. · 2017ReviewGinger — mechanism of action in chemotherapy-induced nausea and vomiting: a reviewView study →Reference 2Al Kury LT et al. · 2018Natural negative allosteric modulators of 5-HT3 receptorsView study →}.

Gap: every antiemetic efficacy trial used whole rhizome or standardised extract; there is no human trial of purified ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol, and the effect cannot be apportioned between gingerols, shogaols and the volatile oil ^{13Reference 13Viljoen E et al. · 2014Meta-analysisA systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomitingView study →}.

2. Anti-inflammatory / OA / dysmenorrhea

Ginger supplementation lowers CRP, TNF-α and oxidative-stress markers in meta-analyses of RCTs ^{3,4Reference 3Jalali M et al. · 2020Meta-analysisThe effects of ginger supplementation on markers of inflammatory and oxidative stress: a systematic review and meta-analysisView study →Reference 4Sheikhhossein F et al. · 2021Meta-analysisEffects of ginger supplementation on biomarkers of oxidative stress: a systematic review and meta-analysis of RCTsView study →}, and signals exist for osteoarthritis and primary dysmenorrhea. The isolate mechanism (COX/5-LOX and NF-κB inhibition) is well characterised in vitro ^{10Reference 10Jeong CH et al. · 2009Jeong CH, et al. (2009). [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Research. https://pubmed.ncbi.nlm.nih.gov/19531649/View study →}.

Gap: effect sizes are modest and heterogeneous, and the human data are ginger extract, not isolated ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol ^{3,4Reference 3Jalali M et al. · 2020Meta-analysisThe effects of ginger supplementation on markers of inflammatory and oxidative stress: a systematic review and meta-analysisView study →Reference 4Sheikhhossein F et al. · 2021Meta-analysisEffects of ginger supplementation on biomarkers of oxidative stress: a systematic review and meta-analysis of RCTsView study →}.

3. Metabolic / glycemic

Some meta-analyses report reductions in fasting glucose and HbA1c with ginger in type-2 diabetes ^{11Reference 11Pourmasoumi M et al. · 2022Meta-analysisThe effect of ginger supplementation on metabolic profiles in patients with type-2 diabetes mellitus: a systematic review and meta-analysis of RCTsView study →}; others find no significant effect ^{12Reference 12Zhu J et al. · 2019Meta-analysisDietary ginger as a traditional therapy for blood-sugar control in patients with type-2 diabetes mellitus: a systematic review and meta-analysisView study →}.

Gap: inconsistent, with large dose/duration heterogeneity, and all trials used ginger powder — no isolated-gingerol glycemic trial exists ^{11,12Reference 11Pourmasoumi M et al. · 2022Meta-analysisThe effect of ginger supplementation on metabolic profiles in patients with type-2 diabetes mellitus: a systematic review and meta-analysis of RCTsView study →Reference 12Zhu J et al. · 2019Meta-analysisDietary ginger as a traditional therapy for blood-sugar control in patients with type-2 diabetes mellitus: a systematic review and meta-analysisView study →}.

4. GI motility / prokinetic

^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-Gingerol is a TRPV1 agonist (with a binding mode distinct from capsaicin), and TRPV1 activation drives prokinetic and secretory effects — including reduced gastric-acid secretion — in animal gut ^{8,9Reference 8Yin Y et al. · 2019Structural mechanisms underlying activation of TRPV1 channels by pungent compounds in gingersView study →Reference 9Gould GG et al. · 2012AnimalDietary agonists of TRPV1 inhibit gastric acid secretion in miceView study →}.

Gap: the human prokinetic data are ginger extract; the isolate effect is not clinically quantified ^{8,9Reference 8Yin Y et al. · 2019Structural mechanisms underlying activation of TRPV1 channels by pungent compounds in gingersView study →Reference 9Gould GG et al. · 2012AnimalDietary agonists of TRPV1 inhibit gastric acid secretion in miceView study →}.

5. Anticancer

^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-Gingerol induces apoptosis and cell-cycle arrest and inhibits leukotriene A4 hydrolase in colorectal cancer lines ^{10Reference 10Jeong CH et al. · 2009Jeong CH, et al. (2009). [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Research. https://pubmed.ncbi.nlm.nih.gov/19531649/View study →}.

Gap: entirely cell/animal, and free ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol is near-undetectable in human plasma (see Pharmacokinetics), so systemic exposure to the active concentrations is implausible ^{6,10Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →Reference 10Jeong CH et al. · 2009Jeong CH, et al. (2009). [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Research. https://pubmed.ncbi.nlm.nih.gov/19531649/View study →}.

Mechanisms

Target / pathway	Effect	Relevant to
5-HT3 receptor (negative allosteric modulation) + NK-1 antagonism	↓ emetic signalling	antiemetic
TRPV1 (vanilloid) agonism	Ca²⁺ influx, sensory activation, ↓ gastric acid, prokinetic	GI, analgesic, thermogenic
COX-2 / 5-LOX / PGE₂ + leukotriene A4 hydrolase inhibition	↓ eicosanoid mediators	anti-inflammatory, anticancer (colon)
NF-κB inhibition	↓ TNF-α, IL-6, CRP	anti-inflammatory
Thromboxane synthesis / platelet-aggregation inhibition	antiplatelet	bleeding-interaction basis

Pharmacokinetics

Load-bearing and human-verified. In healthy volunteers given single oral ginger doses of 100–2000 mg, no participant had detectable free ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-, ^{8Reference 8Yin Y et al. · 2019Structural mechanisms underlying activation of TRPV1 channels by pungent compounds in gingersView study →}-, ^{10Reference 10Jeong CH et al. · 2009Jeong CH, et al. (2009). [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Research. https://pubmed.ncbi.nlm.nih.gov/19531649/View study →}-gingerol or ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-shogaol in plasma — all circulated essentially entirely as glucuronide (and sulfate) conjugates, indicating rapid, near-complete presystemic conjugation ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}. Conjugated ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol appeared within about an hour and cleared over roughly 1–3-hour half-lives ^{6,7Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →Reference 7Yu Y et al. · 2011Examination of the pharmacokinetics of active ingredients of ginger in humansView study →}. Net: rapid absorption, extensive first-pass glucuronidation and very low free-drug plasma exposure — the same “conjugated-not-free” pattern seen with curcumin, and a key limit on isolate systemic activity. The thermal conversion of gingerol to shogaol on drying/heating also means fresh (Sheng Jiang) and dried (Gan Jiang) ginger deliver different actives.

Clinical trials

There are essentially no isolated ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol human efficacy trials. All positive human evidence is whole/standardised ginger: pregnancy nausea ^{13Reference 13Viljoen E et al. · 2014Meta-analysisA systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomitingView study →}, inflammation/oxidative markers ^{3,4Reference 3Jalali M et al. · 2020Meta-analysisThe effects of ginger supplementation on markers of inflammatory and oxidative stress: a systematic review and meta-analysisView study →Reference 4Sheikhhossein F et al. · 2021Meta-analysisEffects of ginger supplementation on biomarkers of oxidative stress: a systematic review and meta-analysis of RCTsView study →} and glycemic endpoints ^{11,12Reference 11Pourmasoumi M et al. · 2022Meta-analysisThe effect of ginger supplementation on metabolic profiles in patients with type-2 diabetes mellitus: a systematic review and meta-analysis of RCTsView study →Reference 12Zhu J et al. · 2019Meta-analysisDietary ginger as a traditional therapy for blood-sugar control in patients with type-2 diabetes mellitus: a systematic review and meta-analysisView study →}; the human pharmacokinetic studies dosed ginger extract and measured gingerol/shogaol conjugates ^{6,7Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →Reference 7Yu Y et al. · 2011Examination of the pharmacokinetics of active ingredients of ginger in humansView study →}. Attribute efficacy to “ginger,” not the isolate.

Last checked: July 2026.

Toxicity & Safety

Ginger and its gingerols are recognised as safe at culinary levels and were well tolerated in human pharmacokinetic dosing up to a 2 g single dose ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}. The main practical caution is antiplatelet activity: gingerols inhibit thromboxane synthesis and platelet aggregation ^{5Reference 5Hirsch GE et al. · 2017Natural products with antiplatelet actionView study →}, so caution is reasonable with anticoagulants or antiplatelets (warfarin, DOACs, aspirin, clopidogrel) and around surgery — though clinical bleeding events are rare and mostly theoretical. High intakes can cause heartburn, reflux or mild GI upset. Additive glucose- and blood-pressure-lowering are plausible, and a CYP interaction is in-vitro only — do not assert it as a confirmed human interaction.

Dosage

There is no established isolated-^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →}-gingerol human dose. Efficacy trials clustered around 0.5–2 g/day of standardised dried ginger, and human pharmacokinetic dose-ranging used single ginger doses of 100–2000 mg ^{6Reference 6Zick SM et al. · 2008Clinical trialPharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol and conjugate metabolites in healthy human subjectsView study →} — all ginger extract, not the isolate. Nothing here is a recommendation.

References